Acimtamig - HY-P990710
Catalog #
HY-P990710
Acimtamig (AFM13) is a CD30/CD16A bispecific innate cell engager. Acimtamig binds to the CD16A expressed on natural killer (NK) cells and binds to CD30 on CD30-expressing tumor cells, thereby selectively cross-linking tumor and NK cells. Acimtamig can be used for the study of eripheral T-cell lymphoma (PTCL)[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P990710/Acimtamig-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | Getquote |
| Shipping | Room temperature |
| Application | COVID-19-immunoregulation |
| Alternative Names | AFM13 |
| CAS | 2738880-26-5 |
| MWT | N/A |
| Clinical Information | Phase 2 |
| Target | TNF Receptor |
| Application: | COVID-19-immunoregulation |
|---|